目前冠心病的发病率呈上升趋势,严重危害人类健康。血栓形成是冠心病发病的重要因素,血小板聚集是血栓形成的中心环节,抗血小板聚集治疗在冠心病防治中发挥着重要作用。P2Y12受体拮抗剂作为二磷酸腺苷(ADP)受体拮抗剂的一种,是一类重要的抗血小板聚集药物,在临床上有着广泛的应用。本文根据最新的研究,对临床上应用的各类 P2Y12受体拮抗剂的作用机制、疗效、安全性及不良反应等进行综述,以期为 P2Y12受体拮抗剂的临床用药提供参考。
At present,the morbidity of coronary heart disease is increasing,and the disease poses great harm for people's health. Thrombosis is an important factor in the pathogenesis of coronary heart disease. Platelet aggregation is a central part of thrombosis. Antiplatelet therapy plays an important role in the prevention and treatment of coronary heart disease. P2Y12 receptor antagonists,as one of ADP receptor antagonists,is an important class of antiplatelet agents,which has been widely used. Based on the latest research progress,this review focused on the mechanism of action,efficiency,safety and adverse reactions of P2Y12 receptor antagonists,hoping to provide a reference for the clinical use of P2Y12 receptor antagonists.